MTRL-SCIApr 22
LLM-guided phase diagram construction through high-throughput experimentationRyo Tamura, Haruhiko Morito, Yuna Oikawa et al.
Constructing phase diagrams for multicomponent alloys requires extensive experimental measurements and is a time-consuming task. Here we investigate whether large language models (LLMs) can guide experimental planning for phase diagram construction. In our framework, a general-purpose LLM serves as the experimental planner, suggesting compositions for measurement at each cycle in a closed loop with high-throughput synthesis and X-ray diffraction phase identification. Using this framework, we experimentally constructed the ternary phase diagram of the Co-Al-Ge system at 900 degree C through iterative synthesis and characterization. We compared two strategies that differ in how the initial compositions are selected: one uses predictions from a domain-specific LLM trained on phase diagram data (aLLoyM), while the other relies solely on the general-purpose LLM. The two strategies exhibited complementary strengths. aLLoyM directed the initial measurements toward compositionally complex regions in the interior of the ternary diagram, enabling the earliest discovery of all three novel phases that form only in the ternary system. In contrast, the general-purpose LLM adopted a textbook-like approach which efficiently identified a larger number of phases in fewer cycles. In addition, a simulated benchmark comparing the LLM against conventional machine learning confirmed that the LLM achieves more efficient exploration. The results demonstrate that LLMs have high potential as experimental planners for phase diagram construction.
AIMay 13
NIMO Controller: a self-driving laboratory orchestrator based on the Model Context ProtocolNaruki Yoshikawa, Ryo Tamura
Self-driving laboratories (SDLs) have attracted increasing attention as a means of accelerating scientific discovery; however, developing SDL software remains technically demanding. To improve accessibility, orchestration software frameworks have been proposed to coordinate SDL components. Nevertheless, existing frameworks are primarily designed for human interaction and do not provide standardized interfaces suitable for AI agents. In this work, we propose an SDL software architecture based on the Model Context Protocol (MCP), in which all SDL functionalities are exposed through MCP servers. Following this design principle, we introduce an MCP-based SDL orchestrator, named NIMO Controller. It provides a visual programming interface automatically generated through MCP-based tool discovery, allowing human users to design experimental workflows without writing code. The same MCP backend can also be accessed by AI agents, providing a unified interface for both human users and AI agents. We demonstrate the proposed system through a case study on a color-matching SDL. The results validate the usability of the proposed MCP-based SDL architecture.
ROJan 13, 2024
ORGANA: A Robotic Assistant for Automated Chemistry Experimentation and CharacterizationKourosh Darvish, Marta Skreta, Yuchi Zhao et al. · gatech, nvidia
Chemistry experiments can be resource- and labor-intensive, often requiring manual tasks like polishing electrodes in electrochemistry. Traditional lab automation infrastructure faces challenges adapting to new experiments. To address this, we introduce ORGANA, an assistive robotic system that automates diverse chemistry experiments using decision-making and perception tools. It makes decisions with chemists in the loop to control robots and lab devices. ORGANA interacts with chemists using Large Language Models (LLMs) to derive experiment goals, handle disambiguation, and provide experiment logs. ORGANA plans and executes complex tasks with visual feedback, while supporting scheduling and parallel task execution. We demonstrate ORGANA's capabilities in solubility, pH measurement, recrystallization, and electrochemistry experiments. In electrochemistry, it executes a 19-step plan in parallel to characterize quinone derivatives for flow batteries. Our user study shows ORGANA reduces frustration and physical demand by over 50%, with users saving an average of 80.3% of their time when using it.
LGFeb 23, 2021
Assigning Confidence to Molecular Property PredictionAkshatKumar Nigam, Robert Pollice, Matthew F. D. Hurley et al.
Introduction: Computational modeling has rapidly advanced over the last decades, especially to predict molecular properties for chemistry, material science and drug design. Recently, machine learning techniques have emerged as a powerful and cost-effective strategy to learn from existing datasets and perform predictions on unseen molecules. Accordingly, the explosive rise of data-driven techniques raises an important question: What confidence can be assigned to molecular property predictions and what techniques can be used for that purpose? Areas covered: In this work, we discuss popular strategies for predicting molecular properties relevant to drug design, their corresponding uncertainty sources and methods to quantify uncertainty and confidence. First, our considerations for assessing confidence begin with dataset bias and size, data-driven property prediction and feature design. Next, we discuss property simulation via molecular docking, and free-energy simulations of binding affinity in detail. Lastly, we investigate how these uncertainties propagate to generative models, as they are usually coupled with property predictors. Expert opinion: Computational techniques are paramount to reduce the prohibitive cost and timing of brute-force experimentation when exploring the enormous chemical space. We believe that assessing uncertainty in property prediction models is essential whenever closed-loop drug design campaigns relying on high-throughput virtual screening are deployed. Accordingly, considering sources of uncertainty leads to better-informed experimental validations, more reliable predictions and to more realistic expectations of the entire workflow. Overall, this increases confidence in the predictions and designs and, ultimately, accelerates drug design.